
Nootropics DAO is building the world's most effective global infrastructure for decentralized research, discovery, and commercialization of powerful solutions for human cognitive enhancement. By creating an open-science ecosystem that aligns professional researchers, citizen-scientists, and biohackers to govern a community-directed research and development pipeline with hyper-efficient feedback loops, Nootropics DAO is operating to become the dominant force in the rapidly growing nootropics industry.
Aggregate global demand for cognitive enhancers from pharmaceutical, plant-derived, and food-based sources
Current size of the chemical nootropics and brain health supplements market
Projected size of the chemical nootropics and brain health supplements market (2034)
With the market for memory boosters, focus aids, brain health supplements, and general cognitive enhancers estimated to reach more than $20 Billion over the next decade, the trend is clear. Nootropics, also known as "smart drugs", are here to stay.
Nearly everybody in the world would love to be smarter, sharper, and more
charismatic with a steel-trap memory to boot. And yet, the research budgets of
centralized institutions have virtually ignored mankind's burning desire to
achieve cognitive enhancement. The chase for the "Limitless" pill is real, and
it's not going away any time soon.
With the scientific literature around chemical cognitive enhancers largely fragmented and struggling to keep pace with increasing market demand, an ever-growing number of nootropics users have been forced to self-organize into a fragmented array of online communities. Often centered around a culture of self-experimentation, these communities of citizen scientists generate reams of ancedotal, yet highly valuable, data points that suggest promising areas of further study and potential commercialization.
However, without the agile, resilient infrastructure necessary to translate the N=1 observations and experiences of nootropics users around the world into a well-funded, efficient research and productization pipeline, many promising ideas in this multi-billion dollar industry are simply left to "die on the vine."
By providing a novel, decentralized, BioDAO-style architecture that can supply these pipelines to responsible citizen scientists and professional researchers alike, Nootropics DAO aims to take a "bottom-up" approach in capturing these commercial opportunities to become the dominant player in the nootropics industry. Together, we will use community-directed R&D to open the doors for the world's largest cognitive enhancement communities, professional research bodies, and citizen science collectives to coalesce under one roof and blaze new trails at the edge of humankind's cognitive frontiers.
Nearly everybody in the world would love to be smarter, sharper, and more ...

Compounds which modulate the AMPA, PDE4, NMDA and D4 receptors make promising targets for increasing intelligence, enhancing executive function, maintaining long-term neuronal connections, and more. By targeting very specific brain sites, these selective compounds may usher in the age of personalized, ultra-efficacious cognitive enhancement protocols with minimized side effects.

Discovered by Dr. Vladimir Khavinson beginning in 1973, bioregulator peptides are a powerful class of compounds with decades of data demonstrating an excellent human safety profile and, in many cases, profound effects on neural function. Synergistically combining these peptides with plant-derived nootropics may have major commercial applications.

Selective, partial, and full agonists of the nicotinic acetylcholine receptors have demonstrated profound effects on memory enhancement and long-term learning consolidation in both human and animal models. These compounds have also demonstrated the ability to enhance sensory processing and filtering attention away from distractions.


Engineering the occipital lobe of Nootropics DAO. Architect of benevolent chaos.
The Nootropics DAO has been deliberately designed to hold a unique place in the Bio ecosystem as a BioDAO that simultaneously captures value from a currently active commercial operation, an applied research collective capable of directing user-governed tokenization, and a social layer with a proprietary knowledge base.
More specifically, the Nootropics DAO accrues value through:
- Revenue from DAO-directed R&D, commercialization, and licensing agreements for user-generated formulations.
- Data licensing from new studies on novel and existing nootropics.
- Active wholesale and retail operations of research chemicals for the nootropics and longevity industries. As an active partner of Pump.Science, we have become a trusted supplier and vendor to some of DeSci's fastest-growing operations.
- Revenue-sharing with Chemiax, the trusted commercial partner of NootropicsDAO.
The Nootropics DAO has been deliberately designed to hold a unique place in the Bio ecosystem as a BioDAO that simultaneously captures value from a currently active commercial operation, an applied research collective capable of directing user-govern...


NIH

Food Science and Nutrition Journal

Frontiers Psychiatry Journal